156 related articles for article (PubMed ID: 3913002)
1. Biochemical aspects of drug action and resistance in malaria parasites.
Yuthavong Y; Panijpan B; Ruenwongsa P; Sirawaraporn W
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):459-72. PubMed ID: 3913002
[TBL] [Abstract][Full Text] [Related]
2. The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara.
Onori E
Bull World Health Organ; 1984; 62 Suppl(Suppl):55-62. PubMed ID: 6397277
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms and dynamics of drug resistance in Plasmodium falciparum].
Le Bras J
Bull Soc Pathol Exot; 1999; 92(4):236-41. PubMed ID: 10572658
[TBL] [Abstract][Full Text] [Related]
4. Virulence and drug resistance in malaria parasites.
Stein WD; Sanchez CP; Lanzer M
Trends Parasitol; 2009 Oct; 25(10):441-3. PubMed ID: 19734096
[TBL] [Abstract][Full Text] [Related]
5. The mechanisms of drug resistance in malaria parasites.
Peters W
J Parasitol; 1971 Aug; 57(4):103-7. PubMed ID: 5001106
[No Abstract] [Full Text] [Related]
6. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance of malaria parasites to antifolates.
Gregson A; Plowe CV
Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms and epidemiology of resistances to antimalarials].
Le Bras J; Basco LK; de Pécoulas PE
C R Seances Soc Biol Fil; 1996; 190(4):471-85. PubMed ID: 8952898
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
[TBL] [Abstract][Full Text] [Related]
10. Quinoline resistance mechanisms in Plasmodium falciparum: the debate goes on.
Ward SA; Bray PG; Hawley SR
Parasitology; 1997; 114 Suppl():S125-36. PubMed ID: 9309774
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
Biswas S
Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
[TBL] [Abstract][Full Text] [Related]
12. The chemotherapy of rodent malaria. XII. Substituted tetrahydrofurans, a new chemical family of antimalarials. The action of 2-(p-chlorophenyl)-2-(4-piperidyl)-tetrahydrofuran against Plasmodium berghei and Plasmodium chabaudi.
Peters W
Ann Trop Med Parasitol; 1970 Jun; 64(2):189-202. PubMed ID: 5497391
[No Abstract] [Full Text] [Related]
13. Genetic evidence for Plasmodium falciparum resistance to chloroquine and pyrimethamine in Indochina and the Western Pacific between 1984 and 1998.
Saito-Nakano Y; Tanabe K; Kamei K; Iwagami M; Komaki-Yasuda K; Kawazu S; Kano S; Ohmae H; Endo T
Am J Trop Med Hyg; 2008 Oct; 79(4):613-9. PubMed ID: 18840753
[TBL] [Abstract][Full Text] [Related]
14. The chemotherapy of rodent malaria. 18. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. 5. The blood schizontocidal action of some newer sulphonamides.
Peters W
Ann Trop Med Parasitol; 1973 Jun; 67(2):155-67. PubMed ID: 4578936
[No Abstract] [Full Text] [Related]
15. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname.
Peek R; VAN Gool T; Panchoe D; Greve S; Bus E; Resida L
Am J Trop Med Hyg; 2005 Nov; 73(5):833-8. PubMed ID: 16282289
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
18. Mode of action of antimalarial drugs.
Fitch CD
Ciba Found Symp; 1983; 94():222-32. PubMed ID: 6341003
[TBL] [Abstract][Full Text] [Related]
19. Synergism of cimetidine with anti-malarial agents.
Paciorkowski A; Dai WW; Cerami A; Berger BJ
J Parasitol; 1997 Oct; 83(5):960-3. PubMed ID: 9379310
[TBL] [Abstract][Full Text] [Related]
20. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
Djaman J; Abouanou S; Basco L; Koné M
Sante; 2004; 14(4):205-9. PubMed ID: 15745869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
